BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

201 related articles for article (PubMed ID: 17464308)

  • 1. Intraocular use of rituximab.
    Kitzmann AS; Pulido JS; Mohney BG; Baratz KH; Grube T; Marler RJ; Donaldson MJ; O'Neill BP; Johnston PB; Johnson KM; Dixon LE; Salomao DR; Cameron JD
    Eye (Lond); 2007 Dec; 21(12):1524-7. PubMed ID: 17464308
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Intraocular rituximab.
    Singh AD; Peereboom DM
    Eye (Lond); 2007 Dec; 21(12):1453-4. PubMed ID: 18159211
    [No Abstract]   [Full Text] [Related]  

  • 3. Rituximab penetrates full-thickness retina in contrast to tissue plasminogen activator control.
    Pulido JS; Bakri SJ; Valyi-Nagy T; Shukla D
    Retina; 2007 Oct; 27(8):1071-3. PubMed ID: 18040247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. The pharmacokinetics of rituximab following an intravitreal injection.
    Kim H; Csaky KG; Chan CC; Bungay PM; Lutz RJ; Dedrick RL; Yuan P; Rosenberg J; Grillo-Lopez AJ; Wilson WH; Robinson MR
    Exp Eye Res; 2006 May; 82(5):760-6. PubMed ID: 16289160
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intravitreal methotrexate for treating vitreoretinal lymphoma: 10 years of experience.
    Frenkel S; Hendler K; Siegal T; Shalom E; Pe'er J
    Br J Ophthalmol; 2008 Mar; 92(3):383-8. PubMed ID: 18303160
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A pilot study on ocular safety of intravitreal infliximab in a rabbit model.
    Giansanti F; Ramazzotti M; Vannozzi L; Rapizzi E; Fiore T; Iaccheri B; Degl' Innocenti D; Moncini D; Menchini U
    Invest Ophthalmol Vis Sci; 2008 Mar; 49(3):1151-6. PubMed ID: 18326743
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Transscleral Coulomb-controlled iontophoresis of methylprednisolone into the rabbit eye: influence of duration of treatment, current intensity and drug concentration on ocular tissue and fluid levels.
    Behar-Cohen FF; El Aouni A; Gautier S; David G; Davis J; Chapon P; Parel JM
    Exp Eye Res; 2002 Jan; 74(1):51-9. PubMed ID: 11878818
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravitreal injection of piperacillin.
    Semple HC; Liu JC; Peyman GA
    Ophthalmic Surg; 1989 Aug; 20(8):588-90. PubMed ID: 2779969
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Absence of histologic retinal toxicity of intravitreal bevacizumab in a rabbit model.
    Bakri SJ; Cameron JD; McCannel CA; Pulido JS; Marler RJ
    Am J Ophthalmol; 2006 Jul; 142(1):162-4. PubMed ID: 16815270
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phase I study of intraventricular administration of rituximab in patients with recurrent CNS and intraocular lymphoma.
    Rubenstein JL; Fridlyand J; Abrey L; Shen A; Karch J; Wang E; Issa S; Damon L; Prados M; McDermott M; O'Brien J; Haqq C; Shuman M
    J Clin Oncol; 2007 Apr; 25(11):1350-6. PubMed ID: 17312328
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Retinal toxicity of commercially available intravitreal ketorolac in albino rabbits.
    Komarowska I; Heilweil G; Rosenfeld PJ; Perlman I; Loewenstein A
    Retina; 2009 Jan; 29(1):98-105. PubMed ID: 18626418
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Absence of histologic retinal toxicity of intravitreal nanogold in a rabbit model.
    Bakri SJ; Pulido JS; Mukherjee P; Marler RJ; Mukhopadhyay D
    Retina; 2008 Jan; 28(1):147-9. PubMed ID: 18185152
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term retinal toxicity of intravitreal commercially available preserved triamcinolone acetonide (Kenalog) in rabbit eyes.
    Albini TA; Abd-El-Barr MM; Carvounis PE; Iyer MN; Lakhanpal RR; Pennesi ME; Chevez-Barrios P; Wu SM; Holz ER
    Invest Ophthalmol Vis Sci; 2007 Jan; 48(1):390-5. PubMed ID: 17197559
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using human CD20-transfected murine lymphomatous B cells to evaluate the efficacy of intravitreal and intracerebral rituximab injections in mice.
    Mineo JF; Scheffer A; Karkoutly C; Nouvel L; Kerdraon O; Trauet J; Bordron A; Dessaint JP; Labalette M; Berthou C; Labalette P
    Invest Ophthalmol Vis Sci; 2008 Nov; 49(11):4738-45. PubMed ID: 18552383
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Intravitreal rituximab for the treatment of intraocular relapse of non-Hodgkin's lymphoma].
    Fernández Cañabate E; Fernández-Cañabate S
    Farm Hosp; 2018 Jan; 42(1):20-21. PubMed ID: 29306309
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The safety of intraocular ketorolac in rabbits.
    Margalit E; Kugler LJ; Brumm MV; Meza JL; Kompella UB; Escobar ER; Christensen GR
    Invest Ophthalmol Vis Sci; 2006 May; 47(5):2093-9. PubMed ID: 16639020
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The safety of intraocular methotrexate in silicone-filled eyes.
    Hardwig PW; Pulido JS; Bakri SJ
    Retina; 2008 Oct; 28(8):1082-6. PubMed ID: 18779714
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Vitreoretinal toxicity of acetazolamide following intravitreal administration in the rabbit eye.
    Borhani H; Rahimy MH; Peyman GA
    Ophthalmic Surg; 1994 Mar; 25(3):166-9. PubMed ID: 8196921
    [TBL] [Abstract][Full Text] [Related]  

  • 19. A prospective study of early intraocular pressure changes after a single intravitreal triamcinolone injection.
    Im L; Allingham RR; Singh I; Stinnett S; Fekrat S
    J Glaucoma; 2008 Mar; 17(2):128-32. PubMed ID: 18344759
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Rituximab for intraocular lymphoma.
    Itty S; Pulido JS
    Retina; 2009 Feb; 29(2):129-32. PubMed ID: 19202422
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 11.